Q4 EPS Estimate for United Therapeutics Lowered by Analyst
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a research report issued on Tuesday, February 11th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will post earnings of $6.90 per share for the quarter, […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a research report issued on Tuesday, February 11th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will post earnings of $6.90 per share for the quarter, […]